A to Z

age related macular degeneration

Featured Neuroscience Visual Neuroscience

·October 28, 2022·6 min read

A New Device for Early Diagnosis of Degenerative Eye Disorders

Researchers have developed a new ophthalmological device that can detect degenerative visual problems such as age-related macular degeneration long before the onset of the first symptoms.

Featured Genetics Neuroscience Visual Neuroscience

·April 1, 2023·3 min read

A Potential Cause of Age-Related Macular Degeneration

Researchers have identified rare genetic variants that may drive age-related macular degeneration. The findings could be key to developing new treatments that could slow the progression of AMD.

Featured Neuroscience Visual Neuroscience

·September 7, 2022·4 min read

A Single Protein Could Unlock Age-Related Vision Loss

Determining the structure of vitronectin, a protein implicated in age-related macular degeneration and some neurodegenerative disorders, and using pressure to alter the protein shape may help in the development of new treatments for AMD.

Featured Neuroscience Visual Neuroscience

·January 3, 2023·4 min read

Age-Related Macular Degeneration a Risk Factor for COVID-19 Infection and Severe Disease

More severe COVID-19 outcomes associated with age-related macular degeneration likely arise from a genetic predisposition in addition to higher levels of Pdgf in blood serum.

Featured Neurology Neuroscience Visual Neuroscience

·November 17, 2022·5 min read

Age-Related Macular Degeneration Associated With Serious Forms of Cardiovascular Disease

People with subretinal drusenoid deposits (SDD), a form of age-related macular degeneration, are more likely to have underlying heart damage as a result of heart failure or heart attacks, or other forms of cardiovascular disease associated with increased stroke risk.

Featured Neurology Neuroscience Visual Neuroscience

·July 12, 2022·5 min read

Age-Related Macular Degeneration Is Strongly Associated With Heart Disease and Stroke

Age-related macular degeneration with subretinal drusenoid deposits was associated with high-risk vascular diseases, including increased stroke risk and cardiovascular disease.

Featured Neurology Neuroscience Visual Neuroscience

·March 10, 2021·5 min read

Alzheimer’s Disease Protein Linked to Common Sight Loss

Exposing retinal pigment epithelium cells in mouse models to amyloid-beta resulted in retinal pathologies similar to those seen in human age-related macular degeneration.

Featured Neuroscience Open Neuroscience Articles Visual Neuroscience

·November 21, 2016·5 min read

Alzheimer’s Proteins Could Be At Fault For Leading Cause of Vision Loss in Older People

A new study reports amyloid beta proteins are able to accumulate in the retina and damage it, which may result in age related macular degeneration in older people.

Featured Neuroscience Visual Neuroscience

·December 15, 2022·4 min read

Brain Stimulation Found to Improve Reading Ability in Macular Degeneration Patients

Transcranial direct current stimulation can help improve reading for those with age-related macular degeneration.

Featured Neuroscience Visual Neuroscience

·November 8, 2022·4 min read

Cholesterol and Diabetes Drugs May Lessen Risk of Age Related Macular Degeneration

A new study reports regular usage of medications to control type 2 diabetes and lower cholesterol may decrease the risk of developing age-related macular degeneration.

This shows an image of the cells within an eye

Featured Genetics Neuroscience Open Neuroscience Articles Visual Neuroscience

·January 17, 2023·4 min read

Combining Multiple Maps Reveals New Genetic Risk Factors for Age-Related Macular Degeneration

Study uncovers new genetic risk factors for age-related macular degeneration, a leading cause of vision loss in adults.

Featured Neurology Neuroscience

·April 14, 2020·3 min read

Diet may help preserve cognitive function

Following a Mediterranean diet with greater adherence was linked to the lowest risk of cognitive impairment. High fish and vegetable consumption appeared to have the greatest protective effect against cognitive decline.